Registered dietitian lost 60 pounds with GLP-1 weight loss drug Wegovy. She shares foods to avoid and prioritize to minimize side effects and muscle loss.

A growing number of Americans are trying popular weight-loss drugs touted by celebrities, health care providers and others. Should you?

Insurance coverage for weight-loss drugs has recently increased, but typically only covers branded versions, according to consulting firm Mercer.

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs for millions of people.

GoodRx reports on identifying real Wegovy pens, which come in five colors and lack dose selectors. Counterfeits pose health ...

Patients put on weight loss drugs like Ozempic and Wegovy may start regaining weight within weeks of discontinuing them, a ...

Wegovy, a weight loss drug which reduces cardiovascular risks in obese individuals, launched in India on June 24. Experts break down its benefits and risks.

Wegovy (semaglutide) is an FDA-approved medication for chronic weight management. Learn more about Wegovy, including how it works and potential risks.

Novo Nordisk’s new weight-loss drug helped patients lose even more weight on average than its current Wegovy blockbuster treatment, an early-stage trial showed, as the drugmaker races to develop ...

Novo Nordisk (NVO) launches its blockbuster weight-loss drug Wegovy in India, shortly after rival Eli Lilly (LLY) introduced its popular weight loss/diabetes therapy Mounjaro in the country this ...

Patients who took an experimental drug from Eli Lilly & Co. together with Novo Nordisk A/S’s Wegovy maintained muscle while losing weight, offering a potential solution to one of the key ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also cause pregnancy complications and harm some users. Weight-loss drugs ...